The rational use of drugs as therapeutic agents for the treatment of the alcoholisms

Alcohol

Volumn 15, Issue 2, 1998, Pages 161-177

  Wilcox, R E ^a   McMillen, B A ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ACAMPROSATE; AMANTADINE; AMPEROZIDE; AMPHETAMINE DERIVATIVE; BINALTORPHIMINE; BROMOCRIPTINE; BUPRENORPHINE; BUSPIRONE; CYPRODIME; DESIPRAMINE; FENFLURAMINE; FLUPENTIXOL; MUSCIMOL; NALOXONE; NALTREXONE; NALTRINDOLE; PIMOZIDE; QUINELORANE; SEROTONIN ANTAGONIST; SPIPERONE; TIAPRIDE; UNINDEXED DRUG;

ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; DRUG ABUSE; LIMBIC SYSTEM; MENTAL DISEASE; NOTE; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR OCCUPANCY; REWARD;

EID: 0031910470     PISSN: 07418329     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-8329(97)00051-7     Document Type: Note

References (247)

1. 3 receptor ligands Eur. J. Pharmacol. 281 1995 R7 R9
2. A. Adell R.D. Myers Selective destruction of midbrain raphe nuclei by 5.7-DHT: Is brain 5HT involved in alcohol drinking in Sprague-Dawley rats? Brain Res. 693 1995 70 79
3. Alcohol Alert, NIAAA, No. 24, PH 350 April 1994
4. R.M. Anthenelli M.A. Schuckit Affective and anxiety disorders American Society of Addiction Medicine 1994 1 7 Ch. 3
5. R.F. Anton Neurobehavioral basis for the pharmacotherapy of alcoholism: Current and future directions Alcohol Alcohol 31 1996 43 53
6. R.F. Anton D.H. Moak P.K. Latham The obsessive compulsive drinking scale. A new method of assessing outcome in alcoholism treatment studies Arch. Gen. Psychiatry 53 1996 225 231
7. R.F. Anton M.K. Romach H.R. Kranzler H. Pettinati S. O'Malley K. Mann Pharmacotherapy of alcoholism—10 years of progress Alcohol. Clin. Exp. Res. 20 1996 172A 175A
8. 1a receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons Naunyn Schmiedebergs Arch. Pharmacol. 347 1993 353 362
9. J. Arnt Inhibitory effects on the discriminative stimulus properties of d -amphetamine by classical and newer antipsychotics do not correlate with antipsychotic activity. Relation to effects on the reward system? Psychopharmacology (Berlin) 124 1996 117 125
10. S.C. Aronson J.E. Black C.J. McDougle B.E. Scanley P. Jatlow T.R. Kosten G.R. Heninger L.H. Price Serotonergic mechanisms of mechanisms of cocaine effects in humans Psychopharmacol. 119 1995 179 185
11. M. Avalos C. Mak P. Randall C. Abell S.-W. Kwan R.E. Wilcox Prototype and novel antipsychotic drug interactions with dopamine in C6 glioma cells selectively and stably expressing D2S dopamine receptors Soc. Neuroscience Abstr. 23 1997 1778
12. A. Badiani S.T. Anagnostaras T.E. Robinson The development of sensitization to the psychomotor stimulant effects of amphetamine is enhanced in a novel environment Psychopharmacology (Berlin) 117 1995 443 452
13. A. Badiani K.E. Brownman T.E. Robinson Influence of novel vs. home environments on sensitization to the psychomotor stimulant effects of cocaine and amphetamine Brain Res. 674 1995 291 298
14. Y. Buczek D.M. Tomkins G.A. Higgins E.M. Sellers Dissociation of serotonergic regulation of anxiety and ethanol self-administration: A study with mCPP Beh. Pharmacol. 5 1994 470 484
15. G.F. Butler Textbook of materia medica: Pharmacology and therapeutics 1908 W. B. Saunders Philadelphia
16. S.B. Caine G.F. Koob Pretreatment with the dopamine agonist 7-OH-DPAT shifts the cocaine self-administration dose-effect function to the left under different schedules in the rat Behav. Pharmacol. 6 1995 333 347
17. A.D. Campbell W.J. McBride Serotonin-3 receptor and ethanol-stimulated dopamine release in the nucleus accumbens Pharmacol. Biochem. Behav. 51 1995 835 842
18. A. Carlsson Dopamine receptor agonists: Intrinsic activity vs. state of receptor J. Neural Transm. 57 1983 309 315
19. 3 dopamine receptors to G-proteins FEBS Lett. 315 1993 223 226
20. A.W.K. Chan Drugs to decrease alcohol consumption Sci. Matters 3 1992 6 7
21. J. Chen R. Marmur W. Paredes A. Pulles E.L. Gardner Systemic cocaine challenge after chronic cocaine treatment reveals sensitization of extracellular dopamine levels in nucleus accumbens but direct cocaine perfusion into nucleus accumbens does not: Implications for the neural locus of cocaine sensitization Life Sci. 58 1996 139 146
22. J. Chick C.K. Erickson Amsterdam Consensus Conference Participants Conference Summary Consensus conference on alcohol dependence and the role of pharmacotherapy in its treatment Alcohol. Clin. Exp. Res. 20 1996 391 402
23. C.R. Cloninger M. Bohman S. Sigvardsson Inheritance of alcohol abuse: Cross-fostering analysis of adopted men Arch. Gen. Psychiatry 38 1981 861 868
24. J. Cold NeuRecover-SATM in the treatment of cocaine withdrawal and craving—a pilot study Clin. Drug Invest. 12 1996 1 7
25. J.R. Cornelius I.M. Salloum J.G. Ehler P.J. Jarrett M.D. Cornelius A. Black Fluoxetine vs. placebo in suicidal depressed alcoholics RSA/ISBRA Abstr. 1996 94A
26. J.R. Cornelius I.M. Salloum N.L. Day M.E. Thase J.J. Mann Patterns of suicidality and alcohol use in alcoholics with major depression Alcohol. Clin. Exp. Res. 20 1996 1451 1455
27. J.W. Cornish L.F. McNicholas C.P. O'Brien Treatment of substance-related disorders The American psychiatric press textbook of psychopharmacology 1995 American Psychiatric Press Washington, DC 707 724
28. 2 receptor agonists in the treatment of schizophrenia Psychopharmacol. Bull. 25 1989 393 397
29. J.C. Crabbe J.K. Belknap K.J. Buck Genetic animal models of alcohol and drug abuse Science 264 1994 1715 1723
30. R.J. Craig W.J. Weddington Stimulants and cocaine Principals of addiction medicine 1994 American Society of Addiction Medicine Chevy Chase, MD 1 4
31. J.R. Criado R.-S. Lee G.I. Berg S.J. Henriksen Sensitivity of nucleus accumbens neurons in vivo to intoxicating doses of ethanol Alcohol. Clin. Exp. Res. 19 1995 164 169
32. K.A. Cunningham C.W. Bradberry A.S. Chang M.E.A. Reith The role of serotonin in the actions of psychostimulants: Molecular and pharmacological analyses Behav. Brain Res. 73 1996 93 102
33. K.A. Cunningham J.M. Paris N.E. Goeders Serotonin neurotransmission in cocaine sensitization Ann. NY Acad. Sci. 654 1992 117 127
34. M. Daoust P. Compagnon E. Legrand E. Mocaër Tianeptine, a specific serotonin uptake enhancer, decreases ethanol intake in rats Alcohol Alcohol. 27 1992 15 17
35. D. Davidson R. Swift E. Fitz Naltrexone increases the latency to drink alcohol in social drinkers Alcohol. Clin. Exp. Res. 20 1996 732 739
36. A.W. Deckel E. Vavrousek-Jakuba W.J. Shoemaker Prefrontal cortex levels of 5-HIAA, but not dopamine, predict alcohol consumption in male wistar rats following 6-OHDA lesions Alcohol 12 1995 563 568
37. E.J. Devor Why is there no gene for alcoholism? Behav. Genet. 23 1993 145 151
38. H. DeWit R.A. Wise Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide, but not with the noradrenergic blockers phentolamine or phenoxybenzamine Can. J. Psychol. 31 1977 195 203
39. P. De Witte The role of neurotransmitters in alcohol dependence: Animal research Alcohol Alcohol. 31 1996 13 16
40. G. Di Chiara Psychobiology of the role of dopamine in drug-abuse and addiction Neurosci. Res. Commun. 17 1996 133 143
41. G. Di Chiara The role of dopamine in drug abuse viewed from the perspective of its role in motivation Drug Alcohol Depend. 38 1995 95 137
42. G. Di Chiara R.A. North Neurobiology of opiate abuse Trends Pharmacol. Sci. 13 1992 185 193
43. G. Di Chiara E. Acquas G. Tanda Ethanol as a neurochemical surrogate of conventional reinforcers: The dopamine-opioid link Alcohol 13 1996 13 17
44. G. Di Chiara M. Morelli E. Acquas E. Carboni Functions of dopamine in the extrapyramidal and limbic systems. Clues for the mechanism of drug actions Arznimittel-Forschung/Drug Research 42 1992 231 237
45. S.B. Dunnett T.W. Robbins The functional role of mesotelencephalic dopamine systems Biol. Rev. 67 1992 491 518
46. C.K. Erickson Voice of the victims Alcohol. Clin. Exp. Res. 19 1995 533 534
47. C.K. Erickson Neuropharmacology of addiction. Addictive disease: A hopeful new message from science 1996 1 20 Unpublished handout
48. C.K. Erickson Voices of the afflicted Alcohol. Clin. Exp. Res. 20 1996 1501 1502
49. C.K. Erickson Voices of the afflicted Alcohol. Clin. Exp. Res. 20 1996 1592 1593
50. C.K. Erickson R.T. Spence Pharmacology of addictive drugs Principals of addiction medicine 1994 American Society of Addiction Medicine Chevy Chase, MD 1 8
51. C.K. Erickson J. Chick Consensus conference on the neuropharmacology of alcohol dependence and the role of pharmacotherapy in its treatment Alcohol Alcohol. 31 1996 1 3
52. F. Fadda E. Mosca G. Colombo G.L. Gessa Alcohol-preferring rats: Genetic sensitivity to alcohol-induced stimulation of dopamine metabolism Physiol. Behav. 47 1990 727 729
53. 2 receptor sensitivity in post withdrawal alcoholics Alcohol. Clin. Exp. Res. 19 1995 1520 1524
54. J.C. Froehlich M. Charness G. Wand G. Di Chiara G. Koob The neurobiology of ethanol-opioid interactions in ethanol reinforcement Alcohol. Clin. Exp. Res. 20 1996 181A 186A
55. D.R. Gastfriend Pharmacologic treatment of dual diagnosis Principles of addiction medicine 1994 American Society of Addiction Medicine Chevy Chase, MD 1 8
56. F.H. Gawin Cocaine addiction: Psychology and neurophysiology Science 251 1991 1580 1586
57. C.R. Gerfen The neostriatal mosaic: Multiple levels of compartmental organization Trends Neurosci. 15 1992 133 139
58. B. Geter-Douglass A.L. Riley Dopamine D1 D2 antagonist combinations as antagonists of the discriminative stimulus effects of cocaine Pharmacol. Biochem. Behav. 54 1996 439 451
59. C. Gianoulakis Implications of endogenous opioids and dopamine in alcoholism: Human and basic science studies Alcohol Alcohol. 31 1996 33 42
60. B. Gibbons Alcohol. The legal drug Natl. Geographic Feb. 1992 2 35
61. J. Gingrich M. Caron Recent advances in the molecular biology of dopamine receptors Annu. Rev. Neurosci. 16 1993 299 321
62. R. Gonzales K. Kilanmaa In vivo links between neurochemistry and behavioral effects of ethanol Alcohol. Clin. Exp. Res. 20 1996 203A 209A
63. E. Gordis Alcohol research: Celebrating the past, building the future Alcohol. Clin. Exp. Res. 20 1996 32A 37A
64. A.S. Gordon K. Collier I. Diamond Ethanol regulation of adenosine receptor-dependent cAMP levels is a clonal neural cell line: An in vitro model of cellular tolerance to ethanol Proc. Natl. Acad. Sci. USA 83 1986 2105 2108
65. H.W. Gordon Human neuroscience at National Institute on Drug Abuse: Implications for genetics research Am. J. Med. Genet. 54 1994 300 303
66. D.A. Gorelick Alcohol and cocaine: Clinical and pharmacological interactions Recent Devl. Alcohol 11 1992 37 56
67. D.A. Gorelick A. Paredes Effect of fluoxetine on alcohol consumption in male alcoholics Alcohol. Clin. Exp. Res. 16 1992 261 265
68. D.A. Gorelick Pharmacologic therapies for cocaine and other stimulant addiction Principals of addiction medicine 1994 American Society of Addiction Medicine Chevy Chase, MD 1 9
69. A. Grace L. Parsons F. Weiss D.B. Newlin J. Greeley J. Pead Craving for alcohol and cocaine: From inside the brain to the clinic Alcohol. Clin. Exp. Res. 20 1996 45A 77A
70. B.F. Grant S.P. Chou R.P. Pickering D.S. Hasin Empirical subtypes of DSM-III-R alcohol dependence: United States 1988 Drug Alcohol Depend. 30 1992 75 84
71. B.F. Grant DSM-IV, DSM-III-R, and ICD-10 alcohol and drug abuse/harmful use and dependence, United States; 1992: A nosological comparison Alcohol. Clin. Exp. Res. 20 1996 1481 1488
72. F.S. Hall J.R. Stellar Measurement issued in curve-shift analysis of apomorphine effects on rewarding brain stimulation Pharmacol. Biochem. Behav. 53 1996 417 423
73. W.C. Hall R.L. Talbert L. Ereshefsky Cocaine abuse and its treatment Pharmacotherapy 10 1990 47 65
74. M. Haraguchi H.H. Samson G.A. Tolliver Reduction in oral ethanol self-administration in the rat by the 5-HT uptake blocker fluoxetine Pharmacol. Biochem. Behav. 35 1990 259 262
75. C.A. Heidbreder D. Babovic-Vuksanovice M. Shoaib T.S. Shippenberg Development of behavioral sensitization to cocaine: Influence of kappa opioid receptor agonist J. Pharmacol. Exp. Ther. 275 1995 150 163
76. A. Heinz B. Lichtenberg-Kraag S. Sèllstrüm Baum K. Grèf F. Krÿger M. Dettling H. Rommelspacher Evidence for prolonged recovery of dopaminergic transmission after detoxification in alcoholics with poor treatment outcome J. Neural Transm. 102 1995 149 157
77. J.E. Helzer T.R. Pryzbeck The co-occurrence of alcoholism with other psychiatric disorders Principals of addiciton medicine 1994 American Society of Addiction Medicine Chevy Chase, MD 1 5
78. 2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence Psychopharmacology (Berlin) 116 1994 285 290
79. G.A. Higgins D.M. Tomkins P.J. Fletcher E.M. Sellers Effect of drugs influencing 5-HT function on ethanol drinking and feeding behaviour in rats: Studies using a drinkometer system Neurosci. Biobehav. Rev. 16 1992 535 552
80. J.D. Higley S.J. Suomi M. Linnoila A nonhuman primate model of Type II excessive alcohol consumption? Part 1. Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentrations with diminished social competence correlate with excessive alcohol consumption Alcohol. Clin. Exp. Res. 20 1996 629 642
81. C.W. Hodge M. Haraguchi H. Erickson H.H. Samson Ventral tegmental microinjections of quinpirole decrease ethanol and sucrose-reinforced responding Alcohol. Clin. Exp. Res. 17 1993 370 375
82. C.W. Hodge A.M. Chappelle H.H. Sampson GABAergic transmission in the nucleus accumbens is involved in the termination of ethanol self administration in rats Alcohol. Clin. Exp. Res. 19 1995 1486 1493
83. 2-like receptors in the medial prefrontal cortex in behavior maintained by ethanol and sucrose reinforcement RSA/ISBRA Abstr. 350 1996 62A
84. C.W. Hodge A.M. Chappelle H.H. Samson Dopamine receptors in the medial prefrontal cortex influence ethanol and sucrose-reinforced responding Alcohol. Clin. Exp. Res. 20 1996 1631 1638
85. P.L. Hoffmann B. Tabakoff Alcohol dependence: A commentary on mechanisms Alcohol Alcohol. 31 1996 333 340
86. L.E. Hollister K. Krajewski T. Rustin H. Gillespie Drugs for cocaine dependence: not easy Arch. Gen. Psychiatry 49 1992 905
87. L.L. Howell L.D. Boyd Serotonergic modulation of the behavioral effects of cocaine in the squirrel monkey J. Pharmacol. Exp. Ther. 275 1995 1551
88. C.B. Hubner G.F. Koob Bromocriptine produces decreases in cocaine self-administration in the rat Neuropsychopharmacology 3 1990 101 108
89. 2 dopamine antagonists on cocaine self-administration in the rat Psychopharmacology (Berlin) 105 1991 151 156
90. W.A. Hunt Neuroscience research: How has it contributed to our understanding of alcohol use and alcoholism? A review Alcohol. Clin. Exp. Res. 17 1993 1055 1065
91. W.A. Hunt W.E.M. Lands A role for behavioral sensitization in uncontrolled ethanol intake Alcohol 9 1992 327 328
92. S. Izenwasser B. Heller B.M. Cox Continuous cocaine administration enhances m- but not d-opioid receptor-mediated inhibition of adenylyl cyclase activity in nucleus accumbens Eur. J. Pharmacol. 297 1996 187 191
93. J.H. Jaffe H.R. Kranzler D.A. Ciraulo Drugs used in the treatment of alcoholism J. Mendelson N. Mello Medical diagnosis and treatment of alcoholism 1992 McGraw-Hill, Inc New York 421 461
94. J.H. Jaffe H.R. Kranzler Pharmacologic therapies for alcoholism Principals of addiciton medicine 1994 American Society of Addiction Medicine Chevy Chase, MD 1 11
95. E. Jankowska A. Bidzinski W. Kostowski Alcohol drinking in rats treated with 5,7-dihydroxytryptamine: Effect of 8-OH-DPAT and Tropisetron (ICS 205–930) Alcohol 11 1994 283 288
96. P. Jatlow E.F. McCance C.W. Bradberry J.D. Elsworth J.R. Taylor R.H. Roth Alcohol plus cocaine: The whole is more than the sum of its parts Ther. Drug Monit. 18 1996 460 464
97. C.-E. Johanson C.R. Schuster Cocaine F.E. Bloom D.J. Kupfer Psychopharmacology: The fourth generation of progress 1995 Raven Press New York 1685 1697
98. J.M. Johns L.W. Means M.J. Means B.A. McMillen Prenatal exposure to cocaine I: Effects on gestation, development, and activity in Sprague-Dawley rats Neurotoxicol. Teratol. 14 1992 337 342
99. 3 receptor interactions in animals and humans Drug Dev. Res. 30 1993 153 169
100. E.A. Jones H.L. Williams R.D. Myers B.A. McMillen Neurotransmitter release in the mesolimbic system of rats trained in the conditioned place preference paradign with cocaine (Abstract) Society for Neuroscience 1995 911 361.16
101. D.I. Kable F. Petty A placebo-controlled, double-blind study of fluoxetine in severe alcohol dependence: Adjunctive Pharmacotherapy during and after inpatient treatment Alcohol. Clin. Exp. Res. 20 1996 780 784
102. P.W. Kalivas Interactions between dopamine and excitatory amino acids in behavioral sensitization to psychostimulants Drug Alcohol Depend. 37 1995 95 100
103. K. Kampman J. Volpicelli A. Alterman J. Cornish R. Weinrieb L. Epperson T. Sparkman C. O'Brien Amantadine in the early treatment of cocaine dependence: A double-blind, placebo controlled trial Drug Alcohol Depend. 41 1996 25 33
104. K.K. Kidd A.J. Pakstis C.M. Castiglion J.R. Kidd W.C. Speed D. Goldman W.C. Knowler R.-B. Lu B. Bonne-Tamir DRD2 haplotypes containing the TaqI A1 allele: Implications for alcoholism research Alcohol. Clin. Exp. Res. 20 1996 697 705
105. H.-S. Kim W.-K. Park C.-G. Jang S. Oh Inhibition by MK-801 of cocaine-induced sensitization, conditioned place preference, and dopamine-receptor supersensitivity in mice Brain Res. Bull. 40 1996 201 207
106. T. Kivastik K. Vuorikallas T.P. Pieponen A. Zharkowvsky L. Ahtee Morphine- and cocaine-induced conditioned place preference: Effects of quinpirole and preclamol Pharmacol. Biochem. Beh. 54 1996 371 375
107. E.A. Kiyatkin Functional significance of mesolimbic dopamine Neurosci. Biobehav. Rev. 19 1995 573 598
108. H. Kleber Pharmacotherapy, current and potential, for the treatment of cocaine dependence Clin. Neuropharmacol. 18 Suppl. 1 1995 S96 S109
109. G. Knoblich D. Curtis W.O. Faustman V. Zarcone S. Stewart I. Mefford R. King Increased CSF HVA with craving in long-term abstinent cocaine abusers Biol. Psychiatry 32 1992 96 100
110. G.F. Koob Drugs of abuse: Anatomy, pharmacology and function of reward pathways Trends Pharmacol. Sci. 13 1992 177 184
111. G.F. Koob F. Weiss Pharmacology of drug self-administration Alcohol 7 1990 193 197
112. G.F. Koob Drugs of abuse: anatomy, pharmacology and function of reward pathways Trends Pharmacol. Sci. 13 1992 177 184
113. G.F. Koob Hedonic valence, dopamine and motivation Mol. Psychiatry 1 1996 186 189
114. 1A receptor agonists on ethanol preference in the rat Alcohol 9 1992 283 286
115. H.R. Kranzler J.H. Jaffee Pharmacologic therapies for alcoholism Principals of Addiction Medicine 1994 American Society of Addiction Medicine Chevy Chase, MD 1 11
116. H.R. Kranzler J.A. Burleson J. Brown T.F. Babor Fluoxetine treatment seems to reduce the beneficial effects of cognitive-behavioral therapy in Type B alcoholics Alcohol. Clin. Exp. Res. 20 1996 1534 1541
117. M.J. Kuhar N.S. Pilotte Neurochemical changes in cocaine withdrawal Trends Pharmacol. Sci. 17 1996 260 263
118. K. Kumor M. Sherer J. Jaffe Effects of bromocriptine treatment on subjective and physiological responses to IV cocaine Pharmacol. Biochem. Behav. 33 1989 829 837
119. B.R. Lawford R.M. Young J.A. Rowell J. Qualichefski B.H. Fletcher K. Syndulko T. Ritchie E.P. Noble Bromocriptine in the treatment of alcoholics with the D2 dopamine receptor A1 allele Nature Med. 1 1995 337 341
120. A.D. Le D.M. Tomkins E.M. Sellers Use of serotonin (5-HT) and opiate-based drugs in the pharmacotherapy of alcohol dependence: An overview of the preclinical data Alcohol Alcohol. 31 1996 27 32
121. M. Le Moal H. Simon Mesocorticolimbic dopaminergic network: Functional and regulatory roles Physiol. Rev. 71 1991 155 234
122. H.R. Lesieur Pathological gambling, eating disorders, and the psychoactive substance use disorders Principals of addiction medicine 1994 American Society of Addiction Medicine Chevy Chase, MD 1 6
123. M.J. Lewis Alcohol reinforcement and neuropharmacological therapeutics Alcohol 31 1996 17 25
124. B. Lichtenberg-Kraag T. May L.G. Schmidt H. Rommelspacher Changes of G-protein levels in platelet membranes from alcoholics during short-term and long-term abstinence Alcohol Alcohol. 30 1995 455 464
125. K.Y. Little U.N. Patel T.B. Clark J.D. Butts Alteration of brain dopamine and serotonin levels in cocaine users: A preliminary report Am. J. Psychiatry 153 1996 1216 1218
126. D.M. Lovinger G. White Ethanol potentiation of 5-hydroxytryptamine3 receptor-mediated ion current in neuroblastoma cells and isolated adult mammalian neurons Mol. Pharmacol. 40 1991 263 270
127. 1 dopamine receptor Mol. Pharmacol. 41 1992 652 659
128. 2A dopamine receptors stably expressed in c6 glioma cells. Sodium effects Soc. Neurosci. Abstr. 21 1995 619
129. 1A dopamine receptors stably expressed in clonal cell lines Neuropharmacology 35 1996 549 570
130. C. Mak P.K. Randall S. Burns C. Abell S.-W. Kwan R.E. Wilcox Dopamine agonists have two separable properties: Induction of cellular response and induction of desensitization Soc. Neurosci. Abstr. 20 1994 520
131. E. Malec T. Malec M.A. Gagné M. Dongier Buspirone in the treatment of alcohol dependence: A placebo-controlled trial Alcohol. Clin. Exp. Res. 20 1996 307 312
132. K. Mann The pharmacological treatment of alcohol dependence: Needs and possibilities Alcohol Alcohol. 31 1996 55 58
133. 2 dopamine agonist and antagonist-induced behaviors Psychopharmacology (Berlin) 213 1996 215 221
134. C.S. Martin P.R. Clifford S.A. Maisto M. Earleywine L. Kirisci R. Longbaugh Polydrug use in an inpatient treatment sample of problem drinkers Alcohol. Clin. Exp. Res. 20 1996 413 417
135. B.J. Mason J.H. Kocsis E.C. Ritvo R.B. Cutler A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression J. Am. Med. Assoc. 275 1996 761 767
136. B.A. Mattingly J.K. Rowlett T. Ellison K. Rase Cocaine-induced behavioral sensitization: Effects of haloperidol and SCH 23390 treatments Pharmacol. Biochem. Behav. 53 1996 481 486
137. E.H. McCance-Katz L.H. Price C.J. McDougle T.R. Kosten J.E. Black P.I. Jatlow Concurrent cocaine-ethanol ingestion in humans: Pharmacology, physiology, behavior, and the role of cocaethylene Psychopharmacology (Berlin) 111 1993 39 46
138. C.J. McDougle L.H. Price J.M. Palumbo T.R. Kosten G.R. Heninger H.D. Kleber Dopaminergic responsivity during cocaine abstinence: A pilot study Psychiatry Res. 43 1992 77 85
139. B.A. McMillen S. Walter H.L. Williams R.D. Myers Comparison of the action of the 5-HT2 antagonists amperozide and trazodone on preference for alcohol in rats Alcohol 11 1994 203 206
140. B.A. McMillen H.L. Williams Volitional consumption of ethanol by fawn-hooded rats: Effects of alternative solutions and drug treatments Alcohol 12 1995 345 350
141. B.A. McMillen H.L. Williams R.D. Myers Effect of clozapine, BMY 14802 and tiospirone on the volitional consumption of ethanol by rats Soc. Neurosci. Abstr. 22 1996 1927
142. N.K. Mello J.H. Mendelson M. Bree S.E. Lukas Buprenorphine and naltrexone effects on cocaine self-administration by rhesus monkeys J. Pharmacol. Exp. Ther. 25 1990 926 939
143. N.K. Mello J.H. Mendelson J. Drieze M. Kelly Acute effects of cocaine on prolactin and gonadotropine in female rhesus monkey during the folicular prolactin and gonadotropins in female rhesus monkey during the follicular phase of the menstrual cycle J. Pharmacol. Exp. Ther. 254 1990 815 823
144. J.H. Mendelson N.K. Mello Management of cocaine abuse and dependence Drug Ther. 334 1996 965 972
145. J.H. Mendelson N.K. Mello Management of cocaine abuse and dependence N. Engl. J. Med. 334 1996 965 972
146. G.V. Milton P.K. Randall C.K. Erickson Low dose effect of ethanol on locomotor activity induced by activation of the mesolimbic system Alcohol. Clin. Exp. Res. 19 1995 768 776
147. Y. Mirovsky Y.L. Yu G.C. Wagner A. Sekowski M. Goldberg H. Fisher Novel synergistic treatment of ethanol withdrawal seizures in rats with dopamine and serotonin agonists Alcohol. Clin. Exp. Res. 19 1995 160 163
148. M.A. Morency R.J. Beninger Dopaminergic substrates of cocaine-induced place conditioning Brain Res. 399 1986 33 41
149. K.T. Mueser P.R. Yarnold D.F. Levinson H. Singh A.S. Bellack K. Kee R.L. Morrison K.G. Yadalam Prevalence of substance abuse in schizophrenia: Demographic and clinical correlates Schizophr. Bull. 16 1990 31 56
150. R.D. Myers New drugs for the treatment of experimental alcoholism Alcohol 11 1994 439 451
151. C. Naranjo C. Poulos K. Bremmer K. Lanctot Citalopram decreases desirability, liking, and consumption of alcohol in alcohol-dependent drinkers Clin. Trials Ther. 51 1992 729 739
152. S.S. Negus N.K. Mello X. Lamas J.H. Mendelson Acute and chronic effects of flupentixol on the discriminative stimulus and reinforcing effects of cocaine in rhesus monkey J. Pharmacol. Exp. Ther. 278 1996 879 890
153. E.J. Nestler Molecular mechanisms of drug addiction J. Neurosci. 12 1992 2439 2450
154. E.J. Nestler M.T. Berhow E.S. Brodkin Molecular mechanisms of drug addiction: Adaptations in signal transduction pathways Mol. Psychiatry 1 1996 190 199
155. E.J. Nestler X. Guitart J. Orditz L. Trevisan Second messenger and protein phosphorylation mechanisms underlying possible genetic vulnerability to alcoholism Ann. NY Acad. Sci. 708 1994 108 118
156. 1A receptors Neuropharmacology 35 1996 119 121
157. G.Y.K. Ng S.R. George Dopamine receptor agonist reduces ethanol self-administration in the ethanol-preferring C57BL/6J inbred mouse Eur. J. Pharmacol. 269 1994 365 374
158. E.P. Noble Alcoholism and the dopaminergic system: A review Addict. Biol. 1 1996 333 348
159. E.P. Noble The gene that rewards alcoholism Sci. Am. Mar/Apr 1996 52 61
160. C. O'Brien Rat study sheds light on cocaine craving Science 271 1996 1499
161. R.E. Olson D. Gursey J. Vester Evidence for a defect in tryptophan metabolism in chronic alcoholism N. Engl. J. Med. 263 1960 1169 1174
162. S. O'Malley Opioid antagonists in the treatment of alcohol dependence: Clinical efficacy and prevention of relapse Alcohol Alcohol. 31 1996 77 81
163. S.S. O'Malley Current strategies for the treatment of alcohol dependence in the United States Drug Alcohol Depend 39 1995 s3 s7
164. S.S. O'Malley A.J. Jaffe S. Rode B.J. Rounsaville Experience of a “slip” among alcoholics treated with naltrexone or placebo Am. J. Psych. 153 1996 281 283
165. S.S. O'Malley A.J. Jaffe G. Chang S. Rode R. Schottenfeld R.E. Meyer B. Rounsaville Six month follow up of naltrexone and psychotherapy for alcohol dependence Arch. Gen. Psychiatry 53 1996 217 224
166. J.T. O'Neill Voice of the victims—the key to consensus and support for alcoholism research Alcohol Alcohol. 31 1996 83 87
167. D.H. Overstreet R. McArthur Alternatives to naltrexone in animal models Alcohol. Clin. Exp. Res. 20 1996 231A 235A
168. W.H.T. Pan J.-C. Sung S.M.R. Fuh Locally application of amphetamine into the ventral tegmental area enhances dopamine release in the nucleus accumbens and the medical prefrontal cortex through noradrenergic neurotransmission J. Pharmacol. Exp. Ther. 278 1996 725 731
169. I. Panocka R. Ciccocioppo R. Ciccocioppo C. Poldori P. Pompei M. Massi The 5-HT4 receptor antagonist, GR113808, reduces ethanol intake in alcohol-preferring rats Pharmacol. Biochem. Beh. 52 1995 255 259
170. A. Parsian R.D. Todd C.R. Cloninger P.L. Hoffman L. Ovchinnikova H. Ikeda B. Tabakoff Members of the WHO/ISBRA Study Clinical Centers.: Platelet adenylyl cyclase activity in alcoholics and subtypes of alcoholics Alcohol. Clin. Exp. Res. 20 1996 745 751
171. L.H. Parsons S.B. Caine P. Sokoloff J.-C. Schwartz G.F. Koob F. Weiss Neurochemical evidence that postsynaptic nucleus accumbens D3 receptor stimulation enhances cocaine reinforcement J. Neurochem. 67 1996 1078 1089
172. M. Pecins-Thompson J. Peris Behavioral and neurochemical changes caused by repeated ethanol and cocaine administration Psychopharmacology (Berlin) 110 1993 443 450
173. E.C. Penick B.J. Powell J. Campbell B.I. Liskow E.J. Nickel T.M. Dales H.M. Thomas L.J. Laster E. Noble Pharmacological treatment for antisocial personality disorder alcoholics: A preliminary study Alcohol. Clin. Exp. Res. 20 1996 477 478
174. D.H. Peters D. Faulds Tiapride: A review of its pharmacology and therapeutic potential in the management of alcohol dependence syndrome Drugs 47 1994 1010 1032
175. A.O. Pfeffer H.H. Samson Haloperidol and apomorphine effects on ethanol reinforcement in free feeding rats Pharmacol. Biochem. Behav. 29 1988 343 350
176. P.V. Piazza M. LeMoal Pathophysiological basis of vulnerability to drug abuse: Role of interaction between stress, glucocorticoids, and dopaminergic neurons Annu. Rev. Pharmacol. Toxicol. 36 1996 359 378
177. K. Poikolainen E. Vartiainen H. Korhonen Alcohol intake and subjective health Am. J. Epidemiol. 144 1996 346 350
178. B.J. Powell J.L. Campbell J.F. Landon B.I. Liskow M.T. Thomas E.J. Nickel T.M. Dale E.C. Penick S.D. Samuelson R.B. Lacoursiere A double blind, placebo-controlled study of nortriptyline and bromocriptine in male alcoholics subtyped by comorbid psychiatric disorders Alcohol. Clin. Exp. Res. 19 1995 462 468
179. S. Prisco S. Pagannone E. Esposito Serotonin-dopamine interaction in the rat ventral tegmental area: an electrophysiological study in vivo J. Pharmacol. Exp. Ther. 271 1994 83 90
180. T.H. Privette R.L. Hornsby R.D. Myers Buspirone alters alcohol drinking induced in rats by tetrahydropapaveroline injected into brain monoaminergic pathways Alcohol 5 1988 147 152
181. L. Pulvirenti G.F. Koob Dopamine receptor agonists, partial agonists and psychostimulant addiction Trends Pharmacol. Sci. 15 1994 374 379
182. L. Pulvirenti G.F. Koob Lisuride reduces intravenous cocaine self-administration in rats Pharmacol. Biochem. Behav. 47 1994 819 822
183. L.D. Reid Endogenous opioids and alcohol dependence: Opioid alkaloids and the propensity to drink alcoholic beverages Alcohol 13 1996 5 11
184. L.D. Reid L.R. Gardell S. Chattopadhyay C.L. Hubbell Periodic naltrexone and propensity to take alcoholic beverage Alcohol. Clin. Exp. Res. 20 1996 1329 1334
185. R.K. Ries Psychotic symptoms Principals of addiction medicine 1994 American Society of Addiction Medicine Chevy Chase, MD 1 10
186. F.O. Risinger R.A. Oakes Serotonergic effects on ethanol-induced conditioned place preference RSA/ISBRA Abstr. 339 1996 60A
187. A.J. Roberts M. Cole G.F. Koob Intra-amygdala muscimol decreases operant ethanol self-administration in dependent rats Alcohol. Clin. Exp. Res. 20 1996 1289 1298
188. T. Robinson K. Berridge The neural basis of drug craving: An incentive-sensitization theory of addiction Brain Res. Rev. 18 1993 247 291
189. P. Robledo R. Maldonado-Lopez G.F. Koob Role of dopamine receptors in the nucleus accumbens in the rewarding properties of cocaine Ann. NY Acad. Sci. 654 1992 509 512
190. J.D. Salamone The behavioral neurochemistry of motivation: Methodological and conceptual issues in studies of the dynamic activity of nucleus accumbens dopamine J. Neurosci. Methods 64 1996 137 149
191. J.D. Salamone The involvement of nucleus accumbens dopamine in appetitive and aversive motivation Behav. Brain Res. 61 1994 117 133
192. J. Samochowiec A. Kleinrok J. Horodnicki The role of dopamine neurotransmission in ethanol dependence development and ethanol withdrawal in rats Pharmazie 50 1995 815 818
193. H.H. Samson G.T. Toliver M. Haraguchi C.W. Hodge Alcohol self-administration: Role of mesolimbic dopamine H.H. Samson P.W. Kalivas The neurobiology of drug and alcohol addiction vol. 654 1992 New York Academy of Science New York 242 253
194. H.H. Samson A.R. Harris Neurobiology of alcohol abuse Trends Pharmacol. Sci. 13 1992 206 211
195. H.H. Samson G.A. Tolliver M. Maraguchi C.W. Hodge Alcohol self-administration: Role of mesolimbic dopamine Ann. NY Acad. Sc. 654 1992 242 253
196. L.G. Schmidt M. Deetling K.-J. Graef A. Heinz S. Kuhn J. Podschus H. Rommelspacher Reduced dopaminergic function in alcoholics is related to severe dependence Biol. Psychol. 39 1996 193 198
197. M.A. Schuckit Dual diagnosis: Psychiatric pictures among substance abusers Principals of addiction medicine 1994 American Society of Addiction Medicine Chevy Chase, MD 1 4
198. G. Schulteis A. Markou J. Cole G.F. Koob Decreased brain reward produced by ethanol withdrawal Proc. Natl. Acad. Sci. USA 92 1995 5880 5884
199. P. Seeman Dopamine receptors and psychosis Sci. Am. Sept/Oct 1995 2 11
200. 4 receptors in schizophrenia J. Neurochem. 64 1994 1413 1415
201. 2-like dopamine receptor agonists Science 271 1996 1586 1589
202. E.M. Sellers G.A. Higgins M.R. Sobell 5-HT and alcohol abuse Trends Pharmacol. Sci. 13 1992 69 75
203. E.M. Sellers T. Toneatto M.K. Romach G.R. Somer L.C. Sobell M.B. Sobell Clinical efficacy of the 5-HT3 antagonist ondansetron in alcohol abuse and dependence Alcohol. Clin. Exp. Res. 18 1994 879 885
204. T.S. Shippenberg C. Heidbreder The d-opioid receptor antagonist naltrindole prevents sensitization to the conditioned rewarding effects of cocaine Eur. J. Pharmacol. 280 1995 55 61
205. T.S. Shippenberg A. LeFevour C. Heidbreder k-Opioid receptor agonists prevent sensitization to the conditioned rewarding effects of cocaine J. Pharmacol. Exp. Ther. 276 1996 545 554
206. D.R. Sibley F.J. Monsma Molecular biology of dopamine receptors Trends Pharmacol. Sci. 13 1992 61 69
207. J.N. Simpson J.Q. Wang J.F. McGinty Repeated amphetamine administration induces a prolonged augmentation of phosphorylated cyclase response element-binding protein and Fos-related antigen immunoreactivity in rat striatum Neuroscience 69 1995 441 457
208. R. Sinha J. Robinson K. Merikangas G.T. Wilson J. Rodin S. O'Malley Eating pathology among women with alcoholism and/or anxiety disorders Alcohol. Clin. Exp. Res. 20 1996 1184 1191
209. S.G. Siris Pharmacological treatment of substance-abusing schizophrenic patients Schizophrenia 16 1990 111 122
210. B.R. Smith L. Pratt J. Horan A. Amit Effect of pimozide on operant responding for ethanol and water: Temporal analysis of suppressant effects RSA/ISBRA Abstr. 343 1996 61A
211. R. Spanagel The influence of opioid antagonists on the discriminative stimulus effects of ethanol Pharmacol. Biochem. Behav. 54 1996 645 649
212. 1 dopamine receptor-mediated immediate-early gene expression in the straitum J. Comp. Neurobiol. 353 1995 200 212
213. I. Stolerman Drugs of abuse: Behavioural principles, methods and terms Trends Pharmacol. Sci. 13 1992 170 176
214. J. Svartengren P. Simmonsson Receptor binding properties of amperozide Pharmacol. Toxicol. 1 1990 8 11
215. B. Tabakoff P.L. Hoffman Alcohol addiction: An enigma among us Neuron 16 1996 909 912
216. B. Tabakoff J.P. Whelan L. Ovchinnikova P. Nhamburo M. Yoshimura P.L. Hoffman Quantitative changes in G proteins do not mediate ethanol-induced down regulation of adenylyl cyclase in mouse cerebral cortex Alcohol. Clin. Exp. Res. 19 1995 187 194
217. A. Tomie Locating reward cue at response manipulandum (CAN) induces symptoms of drug abuse Neurosci. Biobehav. Rev. 20 1996 505 535
218. D.M. Tomkins H.H. Samson C. Fahlke Strategies for revealing the multiple determinants of drinking: Pharmacological and environmental manipulations Alcohol. Clin. Exp. Res. 20 1996 125A 127A
219. G. Torres Acute administration of alcohol blocks cocaine-induced striatal c-fos immunoreactivity protein in the rat Synapse 18 1994 161 167
220. W.M. Turner M.T. Tsuang Impact of substance abuse on the course and outcome of schizophrenia Schizophr. Bull. 16 1990 87 95
221. G.R. Uhl D.J. Vandenbergh L.L. Miner Drug addiction Knockout mice and dirty drugs Curr. Biol. 6 1996 935 936
222. 1 dopamine receptor activation is necessary for the induction of sensitization by amphetamine in the ventral tegmental area J. Neurosci. 16 1996 2411 2420
223. J.R. Volpicelli A.I. Alterman M.O. Hayashida C.P. O'Brien Naltrexone in the treatment of alcohol dependence Arch. Gen. Psychol. 49 1992 876 880
224. J.R. Volpicelli N.T. Watson A.C. King C.E. Sherman C.P. O'Brien Effect of naltrexone on alcohol “high” in alcoholics Am. J. Psychiatry 152 1995 613 615
225. J.L. Waddington S.A. Daly R.P. Downes A.M. Deveney P.G. McCauley K.M. O'Boyle Behavioural pharmacology of “D-1'like” dopamine receptors: Further subtyping, new pharmacological probes and interactions with “D-2'like” receptors Prog. Neuropsychopharmacol. Biol. Psychiatry 19 1995 811 831
226. 2 receptor mechanisms in the mediation of extrapyramidal motor functions in the rat Pharmacol. Biochem. Behav. 47 1994 509 513
227. C.J. Wallis S.M. Rezazadeh H. Lal Role of serotonin in ethanol abuse Drug Dev. Res. 30 1993 178 188
228. Y. Wang C.-H. Jeng J.-C. Lin J.-Y. Wang Setotonin modulates ethanol-induced depression in cerebellar Purkinje neurons Alcohol. Clin. Exp. Res. 20 1996 1229 1236
229. M. Watanabe Reward expectancy in primate prefrontal neurons Nature 382 1996 629 632
230. F. Weight B. Porjesz R.A. Harris J.R. West NIAAA 25th Anniversary: Advances in the neuroscience of alcohol Alcohol. Clin. Exp. Res. 20 1996 38A 44A
231. R.D. Weiss Relapse to cocaine abuse after initiating desipramine treatment JAMA 260 1988 2545 2546
232. R. Weissenborn V. Deroche G.F. Koob F. Weiss Effects of dopamine agonists and antagonists on cocaine-induced operant responding for a cocaine-associated stimulus Psychopharmacology (Berlin) 126 1996 311 322
233. F.J. White Synaptic regulation of mesocorticolimbic dopamine neurons Annu. Rev. Neurosci. 19 1996 405 436
234. F.J. White X.-T. Hu S.-F. Zhang M.E. Wolf Repeated administration of cocaine or amphetamine alters neuronal responses to glutamate in the mesoaccumbens dopamine system J. Pharmacol. Exp. Ther. 273 1995 445 454
235. R.E. Wilcox R.A. Gonzales Introduction to neurotransmitters, receptors, signal transduction and second messenger C.B. Nemeroff A.F. Schatzberg Textbook of psychopharmacology 1995 American Psychiatric Press New York 3 31
236. R.A. Wise Addictive drugs and brain stimulation reward Annu. Rev. Neurosci. 19 1996 319 340
237. R.A. Wise P. Leone R. Rivest K. Leeb Elevations of nucleus accumbens dopamine and DOPAC levels during intravenous heroin self administration Synapse 21 1995 140 148
238. 2-type contributions to psychomotor sensitization and reward: Impliations for pharmacological treatment strategies Clin. Neuropharmacol. 18 1995 S74 S83
239. Wise, R. A.; Kelsey, J. E.: Behavioral models of addiction. Manuscript.
240. J. Wolffgramm A. Heyne From controlled drug intake to loss of control: the irreversible development of drug addiction in the rat Behavioural Brain Res 70 1995 77 94
241. J.J. Woodward Alcohol Principals of addiction medicine 1994 American Society of Addiction Medicine Chevy Chase, MD 1 12
242. W.L. Woolverton K.M. Johnson Neurobiology of cocaine abuse Trends Pharmacol. Sci. 13 1992 193 200
243. 2 dopamine antagonist on behavior maintained by cocaine or food Pharmacol. Biochem. Behav. 32 1989 691 697
244. M.R. Yeomans R.W. Gray Selective effects of naltrexone on food pleasantness and intake Physiol. Behav. 60 1996 439 446
245. K. Yoshimoto W.J. McBride L. Lumeng T.-K. Li Ethanol enhances the release of dopamine and serotonin in the nucleus accumbens of HAD and LAD lines of rats Alcohol. Clin. Exp. Ther. 16 1992 781 785
246. P.A. Zaki E.J. Bilsky T.W. Vanderah J. Lai C.J. Evans F. Porreca Opioid receptor types and subtypes: The delta receptor as a model Annu. Rev. Pharmacol. Toxicol. 36 1996 379 401
247. F.C. Zhou J.K. Zhang L. Lumeng T.K. Li Mesolimbic dopamine system in alcohol-preferring rats Alcohol 12 1995 403 412